DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Doxercalciferol
Doxercalciferol
Label (PDF)
Vitamin D and Its Analogues Decrease Amyloid- (A) Formation
A Clinical Update on Vitamin D Deficiency and Secondary
Specialty Guideline Management Crysvita
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Vitamin D Analog (Oral) Step Therapy Program
Nephrology II BONE METABOLISM and DISEASE in CHRONIC KIDNEY DISEASE
Nuclear Receptors in Renal Disease Moshe Levi
Doxercalciferol)
HECTOROL® Doxercalciferol
A Randomised Clinical Study of Alfacalcidol and Paricalcitol
Article Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol
Calcitriol and Non-Calcemic Vitamin D Analogue, 22-Oxacalcitriol, Attenuate Developmental and Pathological Ocular Angiogenesis Ex Vivo and in Vivo
Article a Randomized Multicenter Trial of Paricalcitol Versus Calcitriol For
Download the CRYSVITA Patient Brochure
Alfacalcidol in CKD-MBD a Fresh Look Brandi, L
Paricalcitol Injection (Zemplar) Reference Number: CP.PHAR.270 Effective Date: 08/16 Coding Implications Last Review Date: 08/17 Revision Log
Doxercalciferol Capsules
Top View
Is There Real Progress?
Ultragenyx and Kyowa Kirin Announce US FDA Approves Label
Alfacalcidol in CKD-MBD - a 5993; Mobile: 45 2054 2458; Email
Crysvita Start Guide
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Control of Secondary Hyperparathyroidism by Vitamin D Receptor Agonists in Chronic Kidney Disease
G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes
Australian Statistics on Medicines 2009
Cinacalcet (Sensipar) Reference Number: ERX.SPA.137 Effective Date: 03.01.14 Last Review Date: 08.18 Revision Log
The Hectorol® Solution
Article a Randomized Multicenter Trial of Paricalcitol Versus Calcitriol For
HECTOROL (Doxercalciferol) Capsule, Liquid Filled [Genzyme Corporation]
Class Review: Vitamin D Analogs
Vitamin D and Glomerulonephritis
Guidelines for ATC Classification and DDD Assignment 2021
(12) Patent Application Publication (10) Pub. No.: US 2004/0053894 A1 Mazess Et Al
Supplementary Table 3
Vitamin D Analogs: Actions and Role in the Treatment of Secondary Hyperparathyroidism Kevin J
SUPPLEMENTARY DATA Supplemental E-Material
The Vitamin Ds Requires Bile
Of 10 HECTOROL INJECTION (Doxercalciferol)
Receptor Activators 3.65 6
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Guidelines for ATC Classification and DDD Assignment 2013
Paricalcitol Injection Reference Number: PA.CP.PHAR.270 Effective Date: 01/18 Coding Implications Last Review Date: 09/18 Revision Log
Summary / Conclusions
Specialty Guideline Management Crysvita
Ultragenyx and Kyowa Kirin Announce Submission of Supplemental Biologics License Application to U.S
Vitamin D Related
Vitamin D Receptor 2016: Novel Ligands and Structural Insights Miguel A
Vitamin D2 Analogs PA
Clinical Policy: Cinacalcet (Sensipar)
Title BIOLOGICAL ROLES of the VITAMIN D RECEPTOR in the REGULATION of TRANSPORTERS and ENZYMES on DRUG DISPOSITION, INCLUDING CY
HECTOROL® (Doxercalciferol) Capsules, for Oral Use Preparations, Thiazide Diuretics, Or Vitamin D Compounds
ATC Code Title
Effects of Cinacalcet and Concurrent Low-Dose Vitamin D on FGF23 Levels in ESRD
Downloaded from Bioscientifica.Com at 09/24/2021 05:12:18PM Via Free Access 64 C S RITTER and a J BROWN